Penn Pharma Invests in Manufacturing Capacity
Penn Pharma has announced plans to invest in additional tablet manufacturing and coating capacity.
Penn Pharma has announced its plans to invest in additional tablet manufacturing and coating capacity to meet customer demand. This investment is in addition to the £14 million ($21.2 million) recently invested in a solid dose contained manufacturing facility to handle potent active pharmaceutical ingredients.
The new £3 million ($4.5 million) investment follows the recent completion of Penn Pharma’s new 15,000-ft2 site for the clinical and commercial manufacture of tablets and capsules.
Penn Pharma has been providing pharmaceutical services for more than 30 years and employs 275 staff on its two sites in South Wales, UK.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
